Gilead Sciences, Inc. company logo
Gilead Sciences, Inc. logo

Gilead Sciences, Inc. (GILD) Cash & Equivalents

Annual Cash & Cash Equivalents

$10.61B$963.00M-8.32%

Summary

Current Value
As of today, GILD annual cash & cash equivalents is $10.61B, down -8.32% on
Historical Performance
GILD annual cash & cash equivalents is up +54.64% over the past 3 years, up +28.37% over the past 5 years
All-Time High Comparison
GILD annual cash & cash equivalents is currently -65.74% below its historical high of $30.95B set on
3-Year Low Comparison
GILD annual cash & cash equivalents is +54.64% above its 3-year low of $6.86B reached on an earlier date
Sector Comparison
GILD annual cash & cash equivalents is higher than 99.21% of companies in Healthcare sector

Cash and Cash Equivalents Chart

SUGGESTED SERIES

Performance

GILD Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash & Cash Equivalents$10.61B-8.3%+54.6%+28.4%+405.3%
Quarterly Cash & Cash Equivalents$4.88B-25.2%-31.2%-28.7%+115.0%
Price$133.06+10.4%+66.3%+90.5%+621.8%
Annual Current Assets$19.89B+3.7%+37.7%+24.3%+248.4%
Annual Total Liabilities$36.40B-8.4%-13.3%-27.5%+565.4%
Annual Working Capital$8.07B+12.6%+151.8%+75.5%+148.9%
Annual Net Income$8.51B+1672.9%+86.4%+9461.8%+194.5%

Cash and Cash Equivalents Highs

GILD Annual Cash & Cash Equivalents Highs Comparison
PeriodHighDateCurrent
3Y$11.57B-8.3%
5Y$11.57B-8.3%
All$30.95B-65.7%

Cash and Cash Equivalents Lows

GILD Annual Cash & Cash Equivalents Lows Comparison
PeriodLowDateCurrent
3Y$6.86BN/A+54.6%
5Y$6.86B+54.6%
All$10.30M>+9999.0%

Cash and Cash Equivalents History

YearValueChange
$10.61B-8.3%
$11.57B+38.5%
$8.35B+21.8%
$6.86B-7.4%
$7.41B-10.4%
$8.26B-66.5%
$24.67B-20.3%
$30.95B+18.4%
$26.15B+119.8%
$11.90B-18.6%
$14.61B+44.2%
$10.13B+375.1%
$2.13B+14.5%
$1.86B-81.2%
$9.90B+371.7%
$2.10B+26.7%
$1.66B-7.4%
$1.79B+52.7%
YearValueChange
$1.17B+25.1%
$936.85M-59.7%
$2.32B+85.3%
$1.25B+77.4%
$707.00M-25.0%
$942.37M+61.7%
$582.85M+13.6%
$512.88M+74.2%
$294.39M+5.2%
$279.94M-13.1%
$322.30M+8.9%
$295.96M+90.1%
$155.66M+35.4%
$114.97M-17.5%
$139.35M+32.2%
$105.42M+923.5%
$10.30M-

FAQ

What is the current annual cash & cash equivalents of GILD?
As of today, GILD annual cash & cash equivalents is $10.61B
What is 1-year change in GILD annual cash & cash equivalents?
GILD annual cash & cash equivalents is down -8.32% year-over-year
What is 3-year change in GILD annual cash & cash equivalents?
GILD annual cash & cash equivalents is up +54.64% over the past 3 years
How far is GILD annual cash & cash equivalents from its all-time high?
GILD annual cash & cash equivalents is currently -65.74% below its historical high of $30.95B set on December 31, 2018
How does GILD annual cash & cash equivalents rank versus sector peers?
GILD annual cash & cash equivalents is higher than 99.21% of companies in Healthcare sector
When is GILD next annual earnings release?
As of today, the next annual earnings release for GILD has not been scheduled

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Data Sources & References

  1. GILD Official Website www.gilead.com
  2. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/882095/000088209526000003/0000882095-26-000003-index.htm
  3. GILD Profile on Yahoo Finance finance.yahoo.com/quote/GILD
  4. GILD Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gild